SOCIETY FOR ENDOCRINOLOGY
Advancement of scientific and clinical education and research in endocrinology for the public benefit through grants, events, research, education of doctors, nurses and scientists, publications and to educate and inform the public and patients through providing support and information on all aspects of endocrinology.
Objects
For the public benefit,To promote and advance the science of endocrinology, including but not restricted to:? Advancing and supporting research in that field, and disseminating theresults of such research.? Advancing the education of the public in the science of endocrinology. Improving the health and wellbeing of people living with, or at risk of, endocrine-related conditions, in particular but not exclusively by:? Developing and promoting high professional standards in the practice ofendocrinology.? Educating and supporting practitioners and professionals working in the fieldof endocrinology.
Financial health, per its FY2025 accounts
The accounts state that the charity achieved a net financial breakeven position for the year ended 31 December 2025, with total group income and expenditure both amounting to £5.3M. The Trustees confirmed that readily available unrestricted reserves of £3.3M exceeded the stated target reserve requirement of £2.3M, indicating a strong financial position.
What the accounts disclose
“The Society’s main source of funds is its journals, received through Gift Aid from Bioscientifica Limited. In 2025, journal income accounted for 50% of the Society’s charitable activities”
“The Society has a wholly owned trading subsidiary, Bioscientifica Limited, which provides publishing, event management and association management services to biomedical communities.” — page 12
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Employees paid over £60,000: 6 (£60,001–£70,000: 2; £70,001–£80,000: 1; £80,001–£90,000: 1; £100,001–£110,000: 1; £120,001–£130,000: 1)
- Has a trading subsidiary
Self-declared on the annual return for the financial year ending 31/12/2024
- Employees paid over £60,000: 5 (£60,001–£70,000: 2; £70,001–£80,000: 1; £90,001–£100,000: 1; £140,001–£150,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/12/2023
- Employees paid over £60,000: 4 (£60,001–£70,000: 2; £90,001–£100,000: 1; £120,001–£130,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
In the news
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- European Society for Endocrinology’s European Journal of Endocrinology announces “Rising Stars” in endocrine research for 2024-26
- Crinetics Pharmaceuticals Presenting New Data from Open Label Extension Trial of Paltusotine in Acromegaly at the Society for Endocrinology BES Congress
- Echocardiography and monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia: A joint position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology - Steeds - 2019 - Cli
- Professor Graham Williams is the new Society for Endocrinology President
Corporate structure
- Registered company of the charity Companies House 00349408
- Trading subsidiary: BIOSCIENTIFICA LIMITED Companies House 03190519
- Turnover: £3.1m
- Profit before tax: £837k
- Donated/gift-aided to the charity: £837k
“The profit on ordinary activities was £837k, and gift aid payments totalling £837k were paid to the parent charity within the financial year.”
Company officers (Companies House)
- COMNINOS, Alexander Nicholas, Professor on trustee list
- BOELAERT, Kristien, Professor on trustee list
- JAMES, Vicki Emma, Dr on trustee list
- TURNER, Mark Christopher, Dr on trustee list
- COLE, Timothy James, Professor on trustee list
- CRISENO, Sherwin on trustee list
- MURPHY, Kevin Graeme, Professor on trustee list
- O'REILLY, Michael, Professor on trustee list
- OKOSIEME, Onyebuchi, Professor on trustee list
- LEVY, Miles Jonathan, Professor on trustee list
- SARGENT, Kate Elizabeth
Property (HM Land Registry)
Structured financials (annual return, FY ending 31/12/2025)
Trustees
- Dr Mark Christopher Turner
- Dr Vicki Emma James
- Professor Alexander Comninos
- Professor Dafydd Aled Rees
- Professor Kevin Graeme Murphy
- Professor Kristien Boelaert
- Professor Mark Gurnell
- Professor Michael O'Reilly
- Professor Miles Jonathan Levy
- Professor Onyebuchi Okosieme
- Professor Timothy James Cole
- Sherwin Criseno
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £5.3m | £5.3m |
| 31/12/2024 | £5.6m | £6.1m |
| 31/12/2023 | £5.5m | £6.2m |
| 31/12/2022 | £6.3m | £7.0m |
| 31/12/2021 | £6.2m | £5.8m |
Common questions
Is SOCIETY FOR ENDOCRINOLOGY financially healthy?
Per its FY2025 accounts: The accounts state that the charity achieved a net financial breakeven position for the year ended 31 December 2025, with total group income and expenditure both amounting to £5.3M. The Trustees confirmed that readily available unrestricted reserves of £3.3M exceeded the stated target reserve requirement of £2.3M, indicating a strong financial position. Its FY2025 accounts were audited by HaysMac LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE COMPANY OF BIOLOGISTS | 1 | £110k |
| PAUL AND LOUISE COOKE ENDOWMENT | 1 | £50k |
| CECIL PILKINGTON CHARITABLE TRUST | 1 | £14k |
| THE ORR MACKINTOSH FOUNDATION LIMITED | 1 | £10k |
| PILKINGTON CHARITIES FUND | 1 | £7k |
| THE BATCHWORTH TRUST | 1 | £5k |
| WHITAKER CHARITABLE TRUST | 1 | £3k |
| THE EDGAR E LAWLEY FOUNDATION | 1 | £2k |
Charities like this
- EUROPEAN SOCIETY OF ENDOCRINOLOGY
- EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY
- ENDOMETRIOSIS UK
- BRITISH SOCIETY FOR NEUROENDOCRINOLOGY
- NEUROENDOCRINE CANCER UK
- FOUNDATION FOR THE SOCIOLOGY OF HEALTH AND ILLNESS
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| SOCIETY FOR ENDOCRINOLOGY | £5.3m | — | — | unclear | — | no doubt |
| EUROPEAN SOCIETY OF ENDOCRINOLOGY | £3.1m | — | 4 | above | — | no doubt |
| EUROPEAN SOCIETY FOR PAEDIATRIC ENDOCRINOLOGY | £1.4m | — | 0 | unclear | — | no doubt |
| ENDOMETRIOSIS UK | £1.5m | — | — | unclear | — | no doubt |
| BRITISH SOCIETY FOR NEUROENDOCRINOLOGY | £554k | — | 0 | above | — | no doubt |
| NEUROENDOCRINE CANCER UK | £696k | — | — | unclear | — | no doubt |